256 related articles for article (PubMed ID: 26014933)
21. Virulence factors and antimicrobial resistance in uropathogenic Escherichiacoli strains isolated from cystitis and pyelonephritis.
Ghazvini H; Taheri K; Edalati E; Sedighi M; Mirkalantari S
Turk J Med Sci; 2019 Feb; 49(1):361-367. PubMed ID: 30761847
[TBL] [Abstract][Full Text] [Related]
22. Putative link between the virulence-associated fluA gene and fluoroquinolone resistance in uropathogenic Escherichia coli.
Lüthje P; Brauner A
J Clin Microbiol; 2010 Feb; 48(2):675-6. PubMed ID: 19955281
[No Abstract] [Full Text] [Related]
23. HlyF, an underestimated virulence factor of uropathogenic Escherichia coli.
Chagneau CV; Payros D; Goman A; Goursat C; David L; Okuno M; Bordignon PJ; Séguy C; Massip C; Branchu P; Ogura Y; Nougayrède JP; Marenda M; Oswald E
Clin Microbiol Infect; 2023 Nov; 29(11):1449.e1-1449.e9. PubMed ID: 37532127
[TBL] [Abstract][Full Text] [Related]
24. Discrepancies in fluoroquinolone clinical categories between the European Committee on Antimicrobial Susceptibility Testing (EUCAST) and CLSI for Escherichia coli harbouring qnr genes and mutations in gyrA and parC.
Rodríguez-Martínez JM; Briales A; Velasco C; Díaz de Alba P; Martínez-Martínez L; Pascual A
J Antimicrob Chemother; 2011 Jun; 66(6):1405-7. PubMed ID: 21427105
[No Abstract] [Full Text] [Related]
25. Whole-genome sequencing of uropathogenic Escherichia coli reveals long evolutionary history of diversity and virulence.
Lo Y; Zhang L; Foxman B; Zöllner S
Infect Genet Evol; 2015 Aug; 34():244-50. PubMed ID: 26112070
[TBL] [Abstract][Full Text] [Related]
26. Comprehensive expression analysis of pathogenicity genes in uropathogenic Escherichia coli strains.
Paniagua-Contreras GL; Hernández-Jaimes T; Monroy-Pérez E; Vaca-Paniagua F; Díaz-Velásquez C; Uribe-García A; Vaca S
Microb Pathog; 2017 Feb; 103():1-7. PubMed ID: 27993701
[TBL] [Abstract][Full Text] [Related]
27. Quinolone resistance mutations in Streptococcus pneumoniae GyrA and ParC proteins: mechanistic insights into quinolone action from enzymatic analysis, intracellular levels, and phenotypes of wild-type and mutant proteins.
Pan XS; Yague G; Fisher LM
Antimicrob Agents Chemother; 2001 Nov; 45(11):3140-7. PubMed ID: 11600369
[TBL] [Abstract][Full Text] [Related]
28. Comparison of extended virulence genotypes for bacteria isolated from pediatric patients with urosepsis, acute pyelonephritis, and acute lobar nephronia.
Cheng CH; Tsau YK; Kuo CY; Su LH; Lin TY
Pediatr Infect Dis J; 2010 Aug; 29(8):736-40. PubMed ID: 20661102
[TBL] [Abstract][Full Text] [Related]
29. MOLECULAR CHARACTERIZATION OF VIRULENCE AND ANTIMICROBIAL SUSCEPTIBILITY PROFILES OF UROPATHOGENIC ESCHERICHIA COLI FROM PATIENTS IN A TERTIARY HOSPITAL, SOUTHERN THAILAND.
Themphachanal M; Kongpheng S; Rattanachuay P; Khianngam S; Singkhamanan K; Sukhumungoon P
Southeast Asian J Trop Med Public Health; 2015 Nov; 46(6):1021-30. PubMed ID: 26867360
[TBL] [Abstract][Full Text] [Related]
30. Characteristics of Romanian fluoroquinolone-resistant human clinical Escherichia coli isolates.
Usein CR; Tatu-Chiţoiu D; Nica M; Ciontea SA; Palade AM; Condei M; Damian M
Roum Arch Microbiol Immunol; 2008; 67(1-2):23-9. PubMed ID: 19284163
[TBL] [Abstract][Full Text] [Related]
31. Molecular Analysis of Uropathogenic E.coli Isolates from Urinary Tract Infections.
Valadbeigi H; Esmaeeli E; Ghafourian S; Maleki A; Sadeghifard N
Infect Disord Drug Targets; 2019; 19(3):322-326. PubMed ID: 30421685
[TBL] [Abstract][Full Text] [Related]
32. Genetic profiles of fluoroquinolone-resistant Escherichia coli isolates obtained from patients with cystitis: phylogeny, virulence factors, PAIusp subtypes, and mutation patterns.
Takahashi A; Muratani T; Yasuda M; Takahashi S; Monden K; Ishikawa K; Kiyota H; Arakawa S; Matsumoto T; Shima H; Kurazono H; Yamamoto S
J Clin Microbiol; 2009 Mar; 47(3):791-5. PubMed ID: 19158256
[TBL] [Abstract][Full Text] [Related]
33. Impact of low-level resistance to fluoroquinolones due to qnrA1 and qnrS1 genes or a gyrA mutation on ciprofloxacin bactericidal activity in a murine model of Escherichia coli urinary tract infection.
Allou N; Cambau E; Massias L; Chau F; Fantin B
Antimicrob Agents Chemother; 2009 Oct; 53(10):4292-7. PubMed ID: 19635960
[TBL] [Abstract][Full Text] [Related]
34. Virulence factors of uropathogenic E. coli and their interaction with the host.
Lüthje P; Brauner A
Adv Microb Physiol; 2014; 65():337-72. PubMed ID: 25476769
[TBL] [Abstract][Full Text] [Related]
35. Defining genomic islands and uropathogen-specific genes in uropathogenic Escherichia coli.
Lloyd AL; Rasko DA; Mobley HL
J Bacteriol; 2007 May; 189(9):3532-46. PubMed ID: 17351047
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of virulence factors and phylogenetic characterization of uropathogenic Escherichia coli causing urinary tract infection in patients with and without diabetes mellitus.
Harwalkar A; Gupta S; Rao A; Srinivasa H
Trans R Soc Trop Med Hyg; 2015 Dec; 109(12):769-74. PubMed ID: 26567223
[TBL] [Abstract][Full Text] [Related]
37. Accumulation of mutations in DNA gyrase and topoisomerase IV genes contributes to fluoroquinolone resistance in Vibrio cholerae O139 strains.
Zhou Y; Yu L; Li J; Zhang L; Tong Y; Kan B
Int J Antimicrob Agents; 2013 Jul; 42(1):72-5. PubMed ID: 23643392
[TBL] [Abstract][Full Text] [Related]
38. Roles of OmpX, an Outer Membrane Protein, on Virulence and Flagellar Expression in Uropathogenic Escherichia coli.
Hirakawa H; Suzue K; Takita A; Kamitani W; Tomita H
Infect Immun; 2021 May; 89(6):. PubMed ID: 33753414
[TBL] [Abstract][Full Text] [Related]
39.
Stærk K; Grønnemose RB; Nielsen TK; Petersen NA; Palarasah Y; Torres-Puig S; Møller-Jensen J; Kolmos HJ; Lund L; Andersen TE
Microbiology (Reading); 2021 Oct; 167(10):. PubMed ID: 34623231
[TBL] [Abstract][Full Text] [Related]
40. Mechanisms of antibiotic resistance in Escherichia coli isolates obtained from healthy children in Spain.
Domínguez E; Zarazaga M; Sáenz Y; Briñas L; Torres C
Microb Drug Resist; 2002; 8(4):321-7. PubMed ID: 12523629
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
